Application value of CT radiomic nomogram in predicting T790M mutation of lung adenocarcinoma

被引:3
|
作者
Li, Xiumei [1 ]
Chen, Jianwei [2 ]
Zhang, Chengxiu [3 ]
Han, Zewen [1 ]
Zheng, Xiuying [1 ]
Cao, Dairong [1 ,4 ,5 ,6 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Fuzhou 350005, Fujian, Peoples R China
[2] Fujian Prov Canc Hosp, Dept Pathol, Fuzhou 350014, Fujian, Peoples R China
[3] East China Normal Univ, Sch Phys & Elect Sci, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Natl Reg Med Ctr, Dept Radiol, Binhai Campus, Fuzhou 350212, Fujian, Peoples R China
[5] Fujian Med Univ, Affiliated Hosp 1, Fujian Key Lab Precis Med Canc, Fuzhou 350005, Fujian, Peoples R China
[6] Fujian Med Univ, Affiliated Hosp 1, Key Lab Radiat Biol, Fujian Higher Educ Inst, Fuzhou 200062, Peoples R China
关键词
Lung adenocarcinoma; Radiomics; Computed tomography; T790M; CANCER;
D O I
10.1186/s12890-023-02609-y
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundThe purpose of this study was to develop a radiomic nomogram to predict T790M mutation of lung adenocarcinoma base on non-enhanced CT lung images.MethodsThis retrospective study reviewed demographic data and lung CT images of 215 lung adenocarcinoma patients with T790M gene test results. 215 patients (including 52 positive) were divided into a training set (n = 150, 36 positive) and an independent test set (n = 65, 16 positive). Multivariate logistic regression was used to select demographic data and CT semantic features to build clinical model. We extracted quantitative features from the volume of interest (VOI) of the lesion, and developed the radiomic model with different feature selection algorithms and classifiers. The models were trained by a 5-fold cross validation strategy on the training set and assessed on the test set. ROC was used to estimate the performance of the clinical model, radiomic model, and merged nomogram.ResultsThree demographic features (gender, smoking, emphysema) and ten radiomic features (Kruskal-Wallis as selection algorithm, LASSO Logistic Regression as classifier) were determined to build the models. The AUC of the clinical model, radiomic model, and nomogram in the test set were 0.742(95%CI, 0.619-0.843), 0.810(95%CI, 0.696-0.907), 0.841(95%CI, 0.743-0.938), respectively. The predictive efficacy of the nomogram was better than the clinical model (p = 0.042). The nomogram predicted T790M mutation with cutoff value was 0.69 and the score was above 130.ConclusionThe nomogram developed in this study is a non-invasive, convenient, and economical method for predicting T790M mutation of lung adenocarcinoma, which has a good prospect for clinical application.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma
    Chen, Quan
    Li, Yan
    Cheng, Qiguang
    Van Valkenburgh, Juno
    Sun, Xiaotian
    Zheng, Chuansheng
    Zhang, Ruiguang
    Yuan, Rong
    ONCOTARGETS AND THERAPY, 2022, 15 : 597 - 608
  • [22] Predicting EGFR mutation subtypes in lung adenocarcinoma using 18F-FDG PET/CT radiomic features
    Liu, Qiufang
    Sun, Dazhen
    Li, Nan
    Kim, Jinman
    Feng, Dagan
    Huang, Gang
    Wang, Lisheng
    Song, Shaoli
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 549 - +
  • [23] Case report of three EGFR TKI naive lung adenocarcinoma containing double EGFR mutations (L858R/T790M or Exon 19 Deletion/T790M); Comparing genetic information and histology
    Sakashita, Shingo
    Shiba-Ishii, Aya
    Murata, Yoshihiko
    Sekimoto, Ryutaro
    Minami, Yuko
    Sato, Yukio
    Noguchi, Masayuki
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (08) : 1224 - 1230
  • [24] CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
    Dongdong Mei
    Yan Luo
    Yan Wang
    Jingshan Gong
    Cancer Imaging, 18
  • [25] CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
    Mei, Dongdong
    Luo, Yan
    Wang, Yan
    Gong, Jingshan
    CANCER IMAGING, 2018, 18
  • [26] Simultaneous Acquisition of T790M Mutation and SCLC Transformation during Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma: A Rare Case Report
    Yazaki, Tatsuya
    Kimoto, Masanobu
    Minagawa, Ayumi
    Maruno, Takashi
    Yamanaka, Miwa
    Sonehara, Kei
    Hama, Mineyuki
    Nakamura, Toshitsugu
    Kanda, Shintaro
    Hanaoka, Masayuki
    Hachiya, Tsutomu
    AMERICAN JOURNAL OF CASE REPORTS, 2024, 25
  • [27] Predicting EGFR T790M Mutation in Brain Metastases Using Multisequence MRI-Based Radiomics Signature
    Li, Ye
    Lv, Xinna
    Wang, Bing
    Xu, Zexuan
    Wang, Yichuan
    Sun, Mengyan
    Hou, Dailun
    ACADEMIC RADIOLOGY, 2023, 30 (09) : 1887 - 1895
  • [28] Benefits of Afatinib and Osimertinib in a Patient with Lung Adenocarcinoma Harboring EGFR19Del/T790M/ G724S Mutation
    Lyu, X.
    Jiao, T.
    Yang, S.
    Yang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S643 - S643
  • [29] Repeated rebiopsy for detection of EGFR T790M mutation in patients with advanced-stage lung adenocarcinoma: Associated factors and treatment outcomes of Osimertinib
    Kim, Taeyun
    Choe, Junsu
    Shin, Sun Hye
    Jeong, Byeong-Ho
    Lee, Kyungjong
    Kim, Hojoong
    Lee, Se-Hoon
    Um, Sang-Won
    PLOS ONE, 2024, 19 (09):
  • [30] Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma
    Su, Kang-Yi
    Tseng, Jeng-Sen
    Liao, Keng-Mao
    Yang, Tsung-Ying
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Yang, Pan-Chyr
    Yu, Sung-Liang
    Chang, Gee-Chen
    PLOS ONE, 2018, 13 (11):